scispace - formally typeset
C

Charles H. Fraga

Researcher at University of Washington

Publications -  13
Citations -  472

Charles H. Fraga is an academic researcher from University of Washington. The author has contributed to research in topics: Vascular permeability & Bronchoalveolar lavage. The author has an hindex of 9, co-authored 13 publications receiving 450 citations. Previous affiliations of Charles H. Fraga include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

The role of proinflammatory cytokines in lung ischemia-reperfusion injury.

TL;DR: Tumor necrosis factor alpha and interleukin 1beta help regulate the development of lung ischemia-reperfusion injury and appear to promote injury by altering expression of proinflammatory and anti-inflammatory cytokines and influencing tissue neutrophil recruitment.
Journal ArticleDOI

Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion.

TL;DR: The potential to pretreat recipients of lung transplantation with statins to ameliorate reperfusion injury is promising and the protective effects of simvastatin are likely mediated by modulation of endothelial nitric oxide synthase.
Journal ArticleDOI

Critical role of reactive nitrogen species in lung ischemia–reperfusion injury

TL;DR: The deleterious effects of lung ischemia-reperfusion injury are in part mediated by the formation of peroxynitrite, as enhanced decomposition of this species is protective in this model.
Journal ArticleDOI

Angiogenic proteins in the lungs of children after cavopulmonary anastomosis.

TL;DR: The results suggest that vascular endothelial growth factor may be a mediator of angiogenesis in the lungs of children after cavopulmonary anastomosis; however, other factors, such as vascular dilation and remodeling, may also be important.
Journal ArticleDOI

Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis.

TL;DR: After cavopulmonary anastomosis, pulmonary microvessel density is increased even in the absence of clinically apparent pulmonary arteriovenous malformations, supporting the presence of a constant angiogenic stimulus.